Korkolopoulou et al. showed that SOX11 overexpression was correlated with improved overall survival in GBM, presenting SOX11 tissue expression as an independent marker of favorable outcome, supporting its tumor suppressor function in astroglial tumors [49]. The gene discussed is SOX11; the disease is neoplasm.